Trials / Conditions / Atypical Teratoid/Rhabdoid Tumor

Atypical Teratoid/Rhabdoid Tumor

19 registered clinical trials studyying Atypical Teratoid/Rhabdoid Tumor — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	GPC3 CAR T Cells With IL-15 and IL-21 for Recurrent ATRT and CNS Rhabdoid Tumors (RADIANT) NCT07513194	Baylor College of Medicine	Phase 1
Not Yet Recruiting	B7-H3.CD28Z.CART in CNS Neoplasms NCT07390539	Robbie Majzner	Phase 1
Recruiting	Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas NCT06465199	Milton S. Hershey Medical Center	Phase 1 / Phase 2
Recruiting	Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation NCT06942039	C17 Council	EARLY_Phase 1
Withdrawn	Trial of Idasanutlin and Selinexor Therapy for Children With Progressive/Relapsed AT/RT or Extra-CNS Malignant NCT05952687	St. Jude Children's Research Hospital	Phase 1
Active Not Recruiting	Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors NCT05407441	Susan Chi, MD	Phase 1 / Phase 2
Suspended	Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children, Adolescents, and Young Adults With Brain Tumo NCT05934630	Pediatric Brain Tumor Consortium	—
Recruiting	Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors NCT05835687	St. Jude Children's Research Hospital	Phase 1
Active Not Recruiting	Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors NCT05286801	National Cancer Institute (NCI)	Phase 1 / Phase 2
Withdrawn	Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer NCT04521946	M.D. Anderson Cancer Center	Phase 1
Active Not Recruiting	Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers NCT04416568	Dana-Farber Cancer Institute	Phase 2
Recruiting	Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Mid NCT04185038	Seattle Children's Hospital	Phase 1
Completed	EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS NCT03638167	Seattle Children's Hospital	Phase 1
Terminated	A Study of Panobinostat in Pediatric Patients With Solid Tumors Including MRT/ATRT NCT04897880	Australian & New Zealand Children's Haematology/Oncology Group	Phase 2
Active Not Recruiting	HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumor NCT03500991	Seattle Children's Hospital	Phase 1
Completed	SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies fo NCT03434262	St. Jude Children's Research Hospital	Phase 1
Completed	Modified Measles Virus (MV-NIS) for Children and Young Adults With Recurrent Medulloblastoma or Recurrent ATRT NCT02962167	Sabine Mueller, MD, PhD	Phase 1
Active Not Recruiting	Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors NCT02114229	St. Jude Children's Research Hospital	Phase 2
Completed	Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors NCT01331135	Emory University	Phase 1